Report cover image

Global Meningitis Vaccine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 98 Pages
SKU # APRC20103028

Description

Summary

According to APO Research, The global Meningitis Vaccine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Meningitis Vaccine include Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Pfizer, GlaxoSmithKline, Beijing Tiantan Biological, Baxter International and Hualan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningitis Vaccine.

The Meningitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (W Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Meningitis Vaccine Segment by Company

Zhejiang Tianyuan
Sanofi Pasteur
Novartis
Merck
Pfizer
GlaxoSmithKline
Beijing Tiantan Biological
Baxter International
Hualan

Meningitis Vaccine Segment by Type

Meningitis A+C
Meningitis ACWY135
Meningitis B

Meningitis Vaccine Segment by Application

Medical Care
Hospital

Meningitis Vaccine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meningitis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

98 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Meningitis Vaccine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Meningitis Vaccine Sales Estimates and Forecasts (2020-2031)
1.3 Meningitis Vaccine Market by Type
1.3.1 Meningitis A+C
1.3.2 Meningitis ACWY135
1.3.3 Meningitis B
1.4 Global Meningitis Vaccine Market Size by Type
1.4.1 Global Meningitis Vaccine Market Size Overview by Type (2020-2031)
1.4.2 Global Meningitis Vaccine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Meningitis Vaccine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.4 South America Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Meningitis Vaccine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Meningitis Vaccine Industry Trends
2.2 Meningitis Vaccine Industry Drivers
2.3 Meningitis Vaccine Industry Opportunities and Challenges
2.4 Meningitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Meningitis Vaccine Revenue (2020-2025)
3.2 Global Top Players by Meningitis Vaccine Sales (2020-2025)
3.3 Global Top Players by Meningitis Vaccine Price (2020-2025)
3.4 Global Meningitis Vaccine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Meningitis Vaccine Major Company Production Sites & Headquarters
3.6 Global Meningitis Vaccine Company, Product Type & Application
3.7 Global Meningitis Vaccine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Meningitis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Meningitis Vaccine Players Market Share by Revenue in 2024
3.8.3 2023 Meningitis Vaccine Tier 1, Tier 2, and Tier 3
4 Meningitis Vaccine Regional Status and Outlook
4.1 Global Meningitis Vaccine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Meningitis Vaccine Historic Market Size by Region
4.2.1 Global Meningitis Vaccine Sales in Volume by Region (2020-2025)
4.2.2 Global Meningitis Vaccine Sales in Value by Region (2020-2025)
4.2.3 Global Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Meningitis Vaccine Forecasted Market Size by Region
4.3.1 Global Meningitis Vaccine Sales in Volume by Region (2026-2031)
4.3.2 Global Meningitis Vaccine Sales in Value by Region (2026-2031)
4.3.3 Global Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Meningitis Vaccine by Application
5.1 Meningitis Vaccine Market by Application
5.1.1 Medical Care
5.1.2 Hospital
5.2 Global Meningitis Vaccine Market Size by Application
5.2.1 Global Meningitis Vaccine Market Size Overview by Application (2020-2031)
5.2.2 Global Meningitis Vaccine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Meningitis Vaccine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.4 South America Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Meningitis Vaccine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Zhejiang Tianyuan
6.1.1 Zhejiang Tianyuan Comapny Information
6.1.2 Zhejiang Tianyuan Business Overview
6.1.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zhejiang Tianyuan Meningitis Vaccine Product Portfolio
6.1.5 Zhejiang Tianyuan Recent Developments
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Comapny Information
6.2.2 Sanofi Pasteur Business Overview
6.2.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Pasteur Meningitis Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments
6.3 Novartis
6.3.1 Novartis Comapny Information
6.3.2 Novartis Business Overview
6.3.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Meningitis Vaccine Product Portfolio
6.3.5 Novartis Recent Developments
6.4 Merck
6.4.1 Merck Comapny Information
6.4.2 Merck Business Overview
6.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Meningitis Vaccine Product Portfolio
6.4.5 Merck Recent Developments
6.5 Pfizer
6.5.1 Pfizer Comapny Information
6.5.2 Pfizer Business Overview
6.5.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Meningitis Vaccine Product Portfolio
6.5.5 Pfizer Recent Developments
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Comapny Information
6.6.2 GlaxoSmithKline Business Overview
6.6.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Meningitis Vaccine Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments
6.7 Beijing Tiantan Biological
6.7.1 Beijing Tiantan Biological Comapny Information
6.7.2 Beijing Tiantan Biological Business Overview
6.7.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Tiantan Biological Meningitis Vaccine Product Portfolio
6.7.5 Beijing Tiantan Biological Recent Developments
6.8 Baxter International
6.8.1 Baxter International Comapny Information
6.8.2 Baxter International Business Overview
6.8.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Baxter International Meningitis Vaccine Product Portfolio
6.8.5 Baxter International Recent Developments
6.9 Hualan
6.9.1 Hualan Comapny Information
6.9.2 Hualan Business Overview
6.9.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hualan Meningitis Vaccine Product Portfolio
6.9.5 Hualan Recent Developments
7 North America by Country
7.1 North America Meningitis Vaccine Sales by Country
7.1.1 North America Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Meningitis Vaccine Sales by Country (2020-2025)
7.1.3 North America Meningitis Vaccine Sales Forecast by Country (2026-2031)
7.2 North America Meningitis Vaccine Market Size by Country
7.2.1 North America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Meningitis Vaccine Market Size by Country (2020-2025)
7.2.3 North America Meningitis Vaccine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Meningitis Vaccine Sales by Country
8.1.1 Europe Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Meningitis Vaccine Sales by Country (2020-2025)
8.1.3 Europe Meningitis Vaccine Sales Forecast by Country (2026-2031)
8.2 Europe Meningitis Vaccine Market Size by Country
8.2.1 Europe Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Meningitis Vaccine Market Size by Country (2020-2025)
8.2.3 Europe Meningitis Vaccine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Meningitis Vaccine Sales by Country
9.1.1 Asia-Pacific Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Meningitis Vaccine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Meningitis Vaccine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Meningitis Vaccine Market Size by Country
9.2.1 Asia-Pacific Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Meningitis Vaccine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Meningitis Vaccine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Meningitis Vaccine Sales by Country
10.1.1 South America Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Meningitis Vaccine Sales by Country (2020-2025)
10.1.3 South America Meningitis Vaccine Sales Forecast by Country (2026-2031)
10.2 South America Meningitis Vaccine Market Size by Country
10.2.1 South America Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Meningitis Vaccine Market Size by Country (2020-2025)
10.2.3 South America Meningitis Vaccine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Meningitis Vaccine Sales by Country
11.1.1 Middle East and Africa Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Meningitis Vaccine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Meningitis Vaccine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Meningitis Vaccine Market Size by Country
11.2.1 Middle East and Africa Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Meningitis Vaccine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Meningitis Vaccine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Meningitis Vaccine Value Chain Analysis
12.1.1 Meningitis Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Meningitis Vaccine Production Mode & Process
12.2 Meningitis Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Meningitis Vaccine Distributors
12.2.3 Meningitis Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.